Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2023 Earnings Call Transcript August 2, 2023
Castle Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $1.01.
Operator: Good afternoon, and welcome to Castle Biosciences Second Quarter 2023 Conference Call. As a reminder, today’s call is being recorded. We will begin today’s call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call over to...
